Summary

The global Bispecific Antibody Medicine market size was US$ 8725 million in 2025 and is forecast to reach a readjusted size of US$ 70500 million by 2032 with a CAGR of 35.3% during the forecast period 2026-2032.
Bispecific antibody medicine, are a type of engineered antibody that can simultaneously recognize and bind to two different antigens or antigen epitopes. Compared with traditional monoclonal antibodies (monospecific antibodies), bispecific antibody drugs have more complex target regulation capabilities and show great therapeutic potential in the fields of tumor immunity, infectious diseases, and autoimmune diseases.
In 2025, the North America Bispecific Antibody Medicine market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of Bispecific Antibody Medicine include Roche (Genentech), Amgen, Regeneron Pharmaceuticals, AstraZeneca, Novartis, Merck & Co., Pfizer, Eli Lilly and Company, Johnson & Johnson, AbbVie, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Bispecific Antibody Medicine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Roche (Genentech)
Amgen
Regeneron Pharmaceuticals
AstraZeneca
Novartis
Merck & Co.
Pfizer
Eli Lilly and Company
Johnson & Johnson
AbbVie
Sanofi
Takeda
Lindis Biotech
Bristol Myers Squibb
Akeso Biopharma
Alphamab Oncology
Innovent Biologics
Wuhan YZY Biopharma Co., Ltd.
BeiGene
Xencor
Zymeworks
MacroGenics, Inc
Genmab
Immunocore Limited
Affimed
Segment by Type
T Cell Redirection Type
Immune Modulation Type
Dual Pathway Blockade Type
Segment by Application
Hospital
Clinic
Others
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market
North America
Europe
China
Japan
India
Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Bispecific Antibody Medicine sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Bispecific Antibody Medicine manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Bispecific Antibody Medicine product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Bispecific Antibody Medicine value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Bispecific Antibody Medicine Product Scope
1.2 Bispecific Antibody Medicine by Type
1.2.1 Global Bispecific Antibody Medicine Sales by Type (2021, 2025 & 2032)
1.2.2 T Cell Redirection Type
1.2.3 Immune Modulation Type
1.2.4 Dual Pathway Blockade Type
1.3 Bispecific Antibody Medicine by Application
1.3.1 Global Bispecific Antibody Medicine Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Bispecific Antibody Medicine Market Estimates and Forecasts (2021-2032)
1.4.1 Global Bispecific Antibody Medicine Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Bispecific Antibody Medicine Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Bispecific Antibody Medicine Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Bispecific Antibody Medicine Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Bispecific Antibody Medicine Historical Market Scenario by Region (2021-2026)
2.2.1 Global Bispecific Antibody Medicine Sales Market Share by Region (2021-2026)
2.2.2 Global Bispecific Antibody Medicine Revenue Market Share by Region (2021-2026)
2.3 Global Bispecific Antibody Medicine Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Bispecific Antibody Medicine Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Bispecific Antibody Medicine Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Bispecific Antibody Medicine Market Size and Prospects (2021-2032)
2.4.2 Europe Bispecific Antibody Medicine Market Size and Prospects (2021-2032)
2.4.3 China Bispecific Antibody Medicine Market Size and Prospects (2021-2032)
2.4.4 Japan Bispecific Antibody Medicine Market Size and Prospects (2021-2032)
2.4.5 India Bispecific Antibody Medicine Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Bispecific Antibody Medicine Historical Market Review by Type (2021-2026)
3.1.1 Global Bispecific Antibody Medicine Sales by Type (2021-2026)
3.1.2 Global Bispecific Antibody Medicine Revenue by Type (2021-2026)
3.1.3 Global Bispecific Antibody Medicine Average Price by Type (2021-2026)
3.2 Global Bispecific Antibody Medicine Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Bispecific Antibody Medicine Sales Forecast by Type (2027-2032)
3.2.2 Global Bispecific Antibody Medicine Revenue Forecast by Type (2027-2032)
3.2.3 Global Bispecific Antibody Medicine Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Bispecific Antibody Medicine
4 Global Market Size by Application
4.1 Global Bispecific Antibody Medicine Historical Market Review by Application (2021-2026)
4.1.1 Global Bispecific Antibody Medicine Sales by Application (2021-2026)
4.1.2 Global Bispecific Antibody Medicine Revenue by Application (2021-2026)
4.1.3 Global Bispecific Antibody Medicine Average Price by Application (2021-2026)
4.2 Global Bispecific Antibody Medicine Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Bispecific Antibody Medicine Sales Forecast by Application (2027-2032)
4.2.2 Global Bispecific Antibody Medicine Revenue Forecast by Application (2027-2032)
4.2.3 Global Bispecific Antibody Medicine Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Bispecific Antibody Medicine Applications
5 Competition Landscape by Players
5.1 Global Bispecific Antibody Medicine Sales by Player (2021-2026)
5.2 Global Top Bispecific Antibody Medicine Players by Revenue (2021-2026)
5.3 Global Bispecific Antibody Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Bispecific Antibody Medicine revenue as of 2025
5.4 Global Bispecific Antibody Medicine Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Bispecific Antibody Medicine, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Bispecific Antibody Medicine, Product Type & Application
5.7 Global Key Manufacturers of Bispecific Antibody Medicine, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Bispecific Antibody Medicine Sales by Company
6.1.1.1 North America Bispecific Antibody Medicine Sales by Company (2021-2026)
6.1.1.2 North America Bispecific Antibody Medicine Revenue by Company (2021-2026)
6.1.2 North America Bispecific Antibody Medicine Sales Breakdown by Type (2021-2026)
6.1.3 North America Bispecific Antibody Medicine Sales Breakdown by Application (2021-2026)
6.1.4 North America Bispecific Antibody Medicine Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Bispecific Antibody Medicine Sales by Company
6.2.1.1 Europe Bispecific Antibody Medicine Sales by Company (2021-2026)
6.2.1.2 Europe Bispecific Antibody Medicine Revenue by Company (2021-2026)
6.2.2 Europe Bispecific Antibody Medicine Sales Breakdown by Type (2021-2026)
6.2.3 Europe Bispecific Antibody Medicine Sales Breakdown by Application (2021-2026)
6.2.4 Europe Bispecific Antibody Medicine Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Bispecific Antibody Medicine Sales by Company
6.3.1.1 China Bispecific Antibody Medicine Sales by Company (2021-2026)
6.3.1.2 China Bispecific Antibody Medicine Revenue by Company (2021-2026)
6.3.2 China Bispecific Antibody Medicine Sales Breakdown by Type (2021-2026)
6.3.3 China Bispecific Antibody Medicine Sales Breakdown by Application (2021-2026)
6.3.4 China Bispecific Antibody Medicine Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Bispecific Antibody Medicine Sales by Company
6.4.1.1 Japan Bispecific Antibody Medicine Sales by Company (2021-2026)
6.4.1.2 Japan Bispecific Antibody Medicine Revenue by Company (2021-2026)
6.4.2 Japan Bispecific Antibody Medicine Sales Breakdown by Type (2021-2026)
6.4.3 Japan Bispecific Antibody Medicine Sales Breakdown by Application (2021-2026)
6.4.4 Japan Bispecific Antibody Medicine Major Customers
6.4.5 Japan Market Trends and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Bispecific Antibody Medicine Sales by Company
6.5.1.1 India Bispecific Antibody Medicine Sales by Company (2021-2026)
6.5.1.2 India Bispecific Antibody Medicine Revenue by Company (2021-2026)
6.5.2 India Bispecific Antibody Medicine Sales Breakdown by Type (2021-2026)
6.5.3 India Bispecific Antibody Medicine Sales Breakdown by Application (2021-2026)
6.5.4 India Bispecific Antibody Medicine Major Customers
6.5.5 India Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Roche (Genentech)
7.1.1 Roche (Genentech) Company Information
7.1.2 Roche (Genentech) Business Overview
7.1.3 Roche (Genentech) Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Roche (Genentech) Bispecific Antibody Medicine Products Offered
7.1.5 Roche (Genentech) Recent Development
7.2 Amgen
7.2.1 Amgen Company Information
7.2.2 Amgen Business Overview
7.2.3 Amgen Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Amgen Bispecific Antibody Medicine Products Offered
7.2.5 Amgen Recent Development
7.3 Regeneron Pharmaceuticals
7.3.1 Regeneron Pharmaceuticals Company Information
7.3.2 Regeneron Pharmaceuticals Business Overview
7.3.3 Regeneron Pharmaceuticals Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Regeneron Pharmaceuticals Bispecific Antibody Medicine Products Offered
7.3.5 Regeneron Pharmaceuticals Recent Development
7.4 AstraZeneca
7.4.1 AstraZeneca Company Information
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.4.4 AstraZeneca Bispecific Antibody Medicine Products Offered
7.4.5 AstraZeneca Recent Development
7.5 Novartis
7.5.1 Novartis Company Information
7.5.2 Novartis Business Overview
7.5.3 Novartis Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Novartis Bispecific Antibody Medicine Products Offered
7.5.5 Novartis Recent Development
7.6 Merck & Co.
7.6.1 Merck & Co. Company Information
7.6.2 Merck & Co. Business Overview
7.6.3 Merck & Co. Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Merck & Co. Bispecific Antibody Medicine Products Offered
7.6.5 Merck & Co. Recent Development
7.7 Pfizer
7.7.1 Pfizer Company Information
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Pfizer Bispecific Antibody Medicine Products Offered
7.7.5 Pfizer Recent Development
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Company Information
7.8.2 Eli Lilly and Company Business Overview
7.8.3 Eli Lilly and Company Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Eli Lilly and Company Bispecific Antibody Medicine Products Offered
7.8.5 Eli Lilly and Company Recent Development
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Company Information
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Johnson & Johnson Bispecific Antibody Medicine Products Offered
7.9.5 Johnson & Johnson Recent Development
7.10 AbbVie
7.10.1 AbbVie Company Information
7.10.2 AbbVie Business Overview
7.10.3 AbbVie Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.10.4 AbbVie Bispecific Antibody Medicine Products Offered
7.10.5 AbbVie Recent Development
7.11 Sanofi
7.11.1 Sanofi Company Information
7.11.2 Sanofi Business Overview
7.11.3 Sanofi Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Sanofi Bispecific Antibody Medicine Products Offered
7.11.5 Sanofi Recent Development
7.12 Takeda
7.12.1 Takeda Company Information
7.12.2 Takeda Business Overview
7.12.3 Takeda Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Takeda Bispecific Antibody Medicine Products Offered
7.12.5 Takeda Recent Development
7.13 Lindis Biotech
7.13.1 Lindis Biotech Company Information
7.13.2 Lindis Biotech Business Overview
7.13.3 Lindis Biotech Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Lindis Biotech Bispecific Antibody Medicine Products Offered
7.13.5 Lindis Biotech Recent Development
7.14 Bristol Myers Squibb
7.14.1 Bristol Myers Squibb Company Information
7.14.2 Bristol Myers Squibb Business Overview
7.14.3 Bristol Myers Squibb Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.14.4 Bristol Myers Squibb Bispecific Antibody Medicine Products Offered
7.14.5 Bristol Myers Squibb Recent Development
7.15 Akeso Biopharma
7.15.1 Akeso Biopharma Company Information
7.15.2 Akeso Biopharma Business Overview
7.15.3 Akeso Biopharma Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.15.4 Akeso Biopharma Bispecific Antibody Medicine Products Offered
7.15.5 Akeso Biopharma Recent Development
7.16 Alphamab Oncology
7.16.1 Alphamab Oncology Company Information
7.16.2 Alphamab Oncology Business Overview
7.16.3 Alphamab Oncology Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.16.4 Alphamab Oncology Bispecific Antibody Medicine Products Offered
7.16.5 Alphamab Oncology Recent Development
7.17 Innovent Biologics
7.17.1 Innovent Biologics Company Information
7.17.2 Innovent Biologics Business Overview
7.17.3 Innovent Biologics Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.17.4 Innovent Biologics Bispecific Antibody Medicine Products Offered
7.17.5 Innovent Biologics Recent Development
7.18 Wuhan YZY Biopharma Co., Ltd.
7.18.1 Wuhan YZY Biopharma Co., Ltd. Company Information
7.18.2 Wuhan YZY Biopharma Co., Ltd. Business Overview
7.18.3 Wuhan YZY Biopharma Co., Ltd. Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.18.4 Wuhan YZY Biopharma Co., Ltd. Bispecific Antibody Medicine Products Offered
7.18.5 Wuhan YZY Biopharma Co., Ltd. Recent Development
7.19 BeiGene
7.19.1 BeiGene Company Information
7.19.2 BeiGene Business Overview
7.19.3 BeiGene Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.19.4 BeiGene Bispecific Antibody Medicine Products Offered
7.19.5 BeiGene Recent Development
7.20 Xencor
7.20.1 Xencor Company Information
7.20.2 Xencor Business Overview
7.20.3 Xencor Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.20.4 Xencor Bispecific Antibody Medicine Products Offered
7.20.5 Xencor Recent Development
7.21 Zymeworks
7.21.1 Zymeworks Company Information
7.21.2 Zymeworks Business Overview
7.21.3 Zymeworks Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.21.4 Zymeworks Bispecific Antibody Medicine Products Offered
7.21.5 Zymeworks Recent Development
7.22 MacroGenics, Inc
7.22.1 MacroGenics, Inc Company Information
7.22.2 MacroGenics, Inc Business Overview
7.22.3 MacroGenics, Inc Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.22.4 MacroGenics, Inc Bispecific Antibody Medicine Products Offered
7.22.5 MacroGenics, Inc Recent Development
7.23 Genmab
7.23.1 Genmab Company Information
7.23.2 Genmab Business Overview
7.23.3 Genmab Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.23.4 Genmab Bispecific Antibody Medicine Products Offered
7.23.5 Genmab Recent Development
7.24 Immunocore Limited
7.24.1 Immunocore Limited Company Information
7.24.2 Immunocore Limited Business Overview
7.24.3 Immunocore Limited Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.24.4 Immunocore Limited Bispecific Antibody Medicine Products Offered
7.24.5 Immunocore Limited Recent Development
7.25 Affimed
7.25.1 Affimed Company Information
7.25.2 Affimed Business Overview
7.25.3 Affimed Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2021-2026)
7.25.4 Affimed Bispecific Antibody Medicine Products Offered
7.25.5 Affimed Recent Development
8 Bispecific Antibody Medicine Manufacturing Cost Analysis
8.1 Bispecific Antibody Medicine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Bispecific Antibody Medicine
8.4 Bispecific Antibody Medicine Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Bispecific Antibody Medicine Distributors List
9.3 Bispecific Antibody Medicine Customers
10 Bispecific Antibody Medicine Market Dynamics
10.1 Bispecific Antibody Medicine Industry Trends
10.2 Bispecific Antibody Medicine Market Drivers
10.3 Bispecific Antibody Medicine Market Challenges
10.4 Bispecific Antibody Medicine Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer